Corey Davis
Stock Analyst at HC Wainwright & Co.
(2.58)
# 2,168
Out of 4,712 analysts
18
Total ratings
66.67%
Success rate
9.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $32 → $26 | $0.95 | +2,633.39% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $1.02 | +4,801.96% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $13.53 | +195.64% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $4.72 | +3,501.69% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $4.81 | +315.80% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $19.81 | +152.40% | 3 | Jan 19, 2018 | |
| CARA Cara Therapeutics | Initiates: Buy | $27 | $0.45 | +5,901.33% | 1 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $125.82 | +14.45% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $32 → $26
Current: $0.95
Upside: +2,633.39%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $1.02
Upside: +4,801.96%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $13.53
Upside: +195.64%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $4.72
Upside: +3,501.69%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $4.81
Upside: +315.80%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $19.81
Upside: +152.40%
Cara Therapeutics
Jan 19, 2018
Initiates: Buy
Price Target: $27
Current: $0.45
Upside: +5,901.33%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $125.82
Upside: +14.45%